Evidence map›Paper›PMID 33976746›Full record

ArticleJournal of Cancer2021

Dextran Sulfate Effects EMT of Human Gastric Cancer Cells by Reducing HIF-1α/ TGF-β.

Yun-Ning Huang, Yuan-Yi Xu, Qian Ma, Meng-Qi Li, Jia-Xin Guo, Xiaofei Wang, Xiu Jin, Jing Shang, Long-Xing Jiao

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. HIF in Gastric Cancer: Regulation and Therapeutic Target.Molecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yun-Ning HuangDepartment of Gastrointestinal Surgery, The Affiliated People's Hospital of Ningxia Medical University, Yinchuan, Ningxia , P.R. China.
Yuan-Yi XuDepartment of Pathology, Ningxia Medical University, Yinchuan, Ningxia, P.R. China.
Qian MaCollege of Life Sciences, Ningxia University, Yinchuan , Ningxia, P.R. China.
Meng-Qi LiDepartment of Pathology, Ningxia Medical University, Yinchuan, Ningxia, P.R. China.
Jia-Xin GuoDepartment of Pathology, Ningxia Medical University, Yinchuan, Ningxia, P.R. China.
Xiaofei WangDepartment of Pathology,North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, P.R. China.
Xiu JinDepartment of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong, P.R. China.
Jing ShangDepartment of Pathology, Ningxia Medical University, Yinchuan, Ningxia, P.R. China.
Long-Xing JiaoDepartment of Pathology, Ningxia Medical University, Yinchuan, Ningxia, P.R. China.
Affiliated Hospital of Jining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The peritoneal implant metastasis is one of the main pathway and main cause for high mortality for gastric cancer metastasis. Researchs show that epithelial-mesenchymal transition (EMT) playing essential role in modulating gastric cancer metastasis, and the expression of hypoxia inducible factor-1α (HIF-1α) can promote EMT in tumor cells. This research aims to explore the influence and mechanism of Dextran Sulfate (DS) affecting EMT of human gastric cancer. In the present study, we found that DS can enter into the cytoplasm and function in it. Inhibition of HIF-1α or DS significantly inhibit the migration and invasion of human gastric cancer cells, and decrease the mRNA and protein expressions of HIF-1α, matrix metalloproteinase-2 (MMP-2), transforming growth factor-β (TGF-β), Twist and N-cadherin (N-cad), rise E-cadherin (E-cad) expression, DS with HIF-1α knockdown has a stronger effect.

Indexed as

Dextran sulfateEMT.HIF-1αHuman gastric cancer

Identifiers

PMID33976746
PMCPMC8100798
OpenAlexW3159066282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.